{"name":"CellTrans Inc.","slug":"celltrans-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Islets of Langerhans transplantation","genericName":"Islets of Langerhans transplantation","slug":"islets-of-langerhans-transplantation","indication":"Type 1 diabetes mellitus with severe hypoglycemia unawareness or brittle diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Islets of Langerhans transplantation","genericName":"Islets of Langerhans transplantation","slug":"islets-of-langerhans-transplantation","phase":"phase_3","mechanism":"Islet transplantation restores functional insulin-producing beta cells to the pancreas, enabling endogenous insulin secretion and glucose homeostasis in patients with type 1 diabetes.","indications":["Type 1 diabetes mellitus with severe hypoglycemia unawareness or brittle diabetes","Type 1 diabetes with impaired kidney function (simultaneous pancreatic islet and kidney transplant)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMnAyd3NOLXdHa1BwME85TEt1VW95eWNBMzIwdUlrd0kxZjJBRlZQUWcwMWprNEZBQjJhNFBhZXFlQV9ScmtGVV8yNDJjLTloeVJaeXZFajBXNkxwWHRFTVVPNlZrUGxhbmNiR1JjbjhPNGp2MmtSYlc3WFdaUEJkaHJXWG0tU2ZkdmFEVm1LbUx1a2l4ZE5zQTJ3QQ?oc=5","date":"2025-03-31","type":"pipeline","source":"MedCity News","summary":"Vertex Cell Therapy Misses in the Clinic, But It Has Other Shots on the Type 1 Diabetes Goal - MedCity News","headline":"Vertex Cell Therapy Misses in the Clinic, But It Has Other Shots on the Type 1 Diabetes Goal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNb1R3V3lCUXk1ZDk3SWNBM2Y4QnM4S2x3NnBOTUtkanplM1ZXN0tJZFRMbGdqUTRsSUlwQWRFYVZUbTRBb1pCYUREcFVZWGtEWFNEMlJMSnptMUs2bklPU0NNdmV6bTBpaE4zYl9uQzJiZWlFY3QtdHFmR2dkY01Ud0h4Z2t4ZTh3RDZyN1pYb056NnJRNFpEVmpXQnhFLThnVmVtRzZLb015SDg?oc=5","date":"2024-07-08","type":"regulatory","source":"TechTarget","summary":"Exploring FDA-approved cell, gene therapeutic products - TechTarget","headline":"Exploring FDA-approved cell, gene therapeutic products","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE0zNXlMLXFqWlhyLXYyN193XzBMRWlRVmd5c3dnZmZlTEdfZTBiQS0zaURjZDI5VXBYd0dIMnRfRzBGZ1drdjZnQzQ0Z21za2M0cmNMeXBINTBMNXd6QWpDelFpYjdTUQ?oc=5","date":"2024-06-26","type":"pipeline","source":"The Pharma Letter","summary":"CellTrans - The Pharma Letter","headline":"CellTrans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPTHZtV0hxTDRhdDBOQWlwLWhkNkdMWnBoOEpzRFNZUk1QanowalEwVnRKZVNzQU9oVDVKSEk1Qlg3UjBXcndxWVowSDlMc3Q5RTlrc2Y3bTlCUExBaGwxSVJLdWlHSVdSVkphTWpkWU9JWjNNR0ZrR2xYZ1BxellkMU1PNy05dDc1UjZERzBrUi14Vk1EWEdGY09Tcy1WTnlfUUREV2ZpV1FTejMxOGZqNFUxMXJoRkd5WHc?oc=5","date":"2024-04-24","type":"pipeline","source":"Fierce Pharma","summary":"Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidates - Fierce Pharma","headline":"Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQNkR2ZlIwRTIxS0pPTVRjM015WG5NZ2tjWjgwYlVHbFlPWGVKa1ltNEdCTERFVkNOd3lNSUxfak5ld3QyS2hpa2hUb1V1dHhkV19CSWdMVzNmV3hKLWxPS0lSajZmb0JCVHMwbVBOSExaMXd6QUVGc1BOcUg4UWFUNjlfSkR3T21FVmN1bHZhOGhBakQ4LW5CME95b0dUOUNGemNGdFo1UlFpbTV6MUdqdkd3cmJNMzYxUDNSWkREZXljZy1vS0F5SS1wVklfaHBXX3lNbWEtMUpXVDZL?oc=5","date":"2024-02-28","type":"pipeline","source":"specialtypharmacycontinuum.com","summary":"Cell and Gene Therapies: A Review of Current and Future Treatments - specialtypharmacycontinuum.com","headline":"Cell and Gene Therapies: A Review of Current and Future Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOZkxqdElQZ1dTTnpTYUkta1Q0M0R2MXJFS3NXai14LXRibXhWV3MxU2F3NUZSUmVlSHRmNFVxTmNtbXI0X2lIaG85cUFCRS0xQmk5UWFXQmlmaUZvMi1NOFBDUTVwLXdLdm9Nck5VM0E0QVZkTGVSN0dpaGtzWnYtc2ZwdWVvQzhHYXRMRUZBN3NjSEUzak9HelJDT1ozN0huWmdCd3ExUjdOVkJWbGpOai1RSGdmV1liV1lqN3ZR?oc=5","date":"2023-10-09","type":"pipeline","source":"Pharmaceutical Technology","summary":"Islet transplantation for type 1 diabetes: Do regulators have it right? - Pharmaceutical Technology","headline":"Islet transplantation for type 1 diabetes: Do regulators have it right?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxORDFPXzBteU9BN2pxOWVnS01fVHN0WVZkMGNpaUlYckZwcnhfbGlYQ0FoVHJEbWxPS1BBb2pSTUpJRjdadko4RzAtVHI0T3hNTmFsdzl4UFpSLTNRWGtLVzJ1RTNOZXFiLXhfSFRaTEhBWlVZSGxnRllkbGNsN254MXBvMFFMRUhCZ3ZvYXlYTG9FNzJQTkExVA?oc=5","date":"2023-07-31","type":"pipeline","source":"Pharmaceutical Technology","summary":"CellTrans’s Lantidra: The first cell therapy to personalise Type 1 diabetes treatment - Pharmaceutical Technology","headline":"CellTrans’s Lantidra: The first cell therapy to personalise Type 1 diabetes treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE80SjR1MjZqMEpsMHF4T3JPYXY5OWpaaE5SNzVkSk1ZQzh3LU1nLUlXaEYzc1ljUVVQcW5FNnhRRk1HNS1ZZ3pZUTRBVkMtZExuN1VlNVhhbjlHT0k3ZF9KMXIwRUJ4NmsydTVFcGJkUFh4UFgxcnpHVVBEUlNTX1E?oc=5","date":"2023-07-02","type":"regulatory","source":"MedCity News","summary":"A Startup Wins the First FDA Approval of a Cell Therapy for Type 1 Diabetes - MedCity News","headline":"A Startup Wins the First FDA Approval of a Cell Therapy for Type 1 Diabetes","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOTmxqYVR2aS1ZekZrbGlWU1NRVXNqTWRtcC1oeGNxbk03clRXclNDaU5yczk4T2RQbWpWZTg5RGthbGhXLTdMNVFUOW9LNWRiVHVjRXc0cjFpcVkwME9NNVpJWXNJOG92YzVxUnQ2QmlMUktkNWJBdzJyQkpRSVBnVElYSk1RcXBNNUZxMjZfb2R4VmlkN1Bud2d5WnB5Tk5Qa25Z?oc=5","date":"2023-06-29","type":"regulatory","source":"Fierce Pharma","summary":"FDA blesses CellTrans' Lantidra, the first cell therapy for Type 1 diabetes - Fierce Pharma","headline":"FDA blesses CellTrans' Lantidra, the first cell therapy for Type 1 diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQcFRScDh3VXlhU3RkVlc2bThJRFhBOEV5WlhJT0tyVlpqNExYa0FXR1NwWnJTTFhLWktnMXJFOVUtbEtEZmt2Z2NFSjJnSm9yRzdqQ1RNU2FlLUZYSkItWnlHUVl3aEU5LUVfczNrTmw4b1F3Y2pTOWZHakx6YndGeXFYOA?oc=5","date":"2023-06-29","type":"regulatory","source":"pharmaphorum","summary":"FDA approves first cell therapy for type 1 diabetes - pharmaphorum","headline":"FDA approves first cell therapy for type 1 diabetes","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}